Inflammation clinical trials
17 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
- Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
- Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control
- Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
- Immune Cell Response to Stimuli
- Natural History of the Human Biological Response to Environmental Exposure and Injury
- Biomarkers in Infection
- Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
- Diagnosis and Management of Inflammatory and Infectious Diseases
- Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
- Evaluating Whether Hyperbaric Oxygen Therapy Can Improve VO₂-Max and Reduce Inflammation Markers in Healthy Adults Ages 30-60.
- Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
- An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines
- Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women
- Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
- Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Inflammation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.